Development and proof-of-concept evaluation for a low resource compatible Chikungunya virus diagnostic
Rickyle Balea(The University of Queensland), David J. McMillan(University of the Sunshine Coast), Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation), Daniel Watterson(The University of Queensland), Jody Hobson‐Peters(The University of Queensland), Andreas Suhrbier(The University of Queensland), Nina M. Pollak(University of Graz), Vasilli Kasimov(University of the Sunshine Coast), Joanne Macdonald(University of the Sunshine Coast)
Cited by 1
Related Papers
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.
|The Journal of Experimental Medicine|1994|281
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
|Cell|2021|236
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
|Proceedings of the National Academy of Sciences|2004|235
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
|Molecular Psychiatry|2022|178
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
|Nature Communications|2021|177